AI-generated summary
The authors randomized 15 men after coronary artery bypass graft surgery to active or placebo low-level laser therapy in a crossover design and measured walking distance, exertion, heart rate, blood pressure and blood markers of tissue damage and oxidative stress. They report no significant differences between active and placebo treatment on any outcome, and conclude that acute laser therapy did not improve exercise capacity or oxidation markers after surgery.
- Participants
- 15
- Who or what was studied
- Fifteen male patients (mean age 60 ± 9 years) after coronary artery bypass graft surgery
- Wavelengths
- 850 nm
- Limits stated in the abstract
- The sample was small (15 men), and the abstract reports only acute, single-session effects in male patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 850 nm
- Power
- 200 mW
- Total energy
- 30 J, 240 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Placebo-controlled, Trial registration, Oxidative stress. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.